Bemaj Pharmacy

Why do antibiotics work if it is not a sinus infection? Does this describe you? “Every time I’m on antibiotics I feel better but when I stop them I feel worse again.” And then a bombshell hits: your doctor tells you that YOU DON’T HAVE A SINUS INFECTION! How could this be? Let’s explore this.

You actually have a resistant or refractory sinus infection. Okay, this is straightforward, find the underlying cause and treat. You do not have a bacterial sinus infection, and the reason for recurrence is that antibiotics are not the best treatment. Many scenarios fit in this category, including but not limited to, allergies, viral colds, and headache syndromes.

But let’s get back to the point. If the condition is NOT a bacterial infection, why would antibiotics make you feel better? There are a few reasons for this phenomenon. Many processes that make a person feel miserable are related to inflammatory responses.

1. The Common Cold causes inflammation in the nasopharyngeal tract.
2. Tension headaches are related to inflammation of the head and face muscles.
3. Certain antibiotics have been shown to reduce inflammation because of its anti-inflamatory properties (1).
4. Hence, raises the question, anti-inflammatory vs antibiotics? Reducing inflammation reduces the symptoms, thereby making it appear that the antibiotics are working.

But if the right diagnosis can be made, better treatments than antibiotics can be considered. A placebo effect is a phenomenon when a drug produces a beneficial effect not attributable to the drug’s properties. Sometimes, the human body will produce its own opioid chemicals (called endogenous opioids) in response to the belief that a treatment works, even if that treatment is a salt-water pill! Thus, some of the effect of antibiotics in nonbacterial conditions can be related to placebo (4).

Some antibiotics appear to modulate the pain centers and processes in the body (2,3), which would make a headache less intense and reduce symptoms of a viral Cold even if no bacteria are present! There are better treatments for these conditions than antibiotics though. So what? So what if it is not a bacteria sinus infection.

If it makes you feel better, why not take antibiotics or antibiotic therapy? This question is great, and you need to know the answer, not just for yourself but for your elderly family member who, as frail as can be, may at any point get a resistant, life-threatening infection.

1. If that is the case then, do we use nonsteroidal anti-inflamatory drugs or anti-inflammatory treatment instead of antibiotic treatment? Bacteria are keen adapters, and they become resistant to antibiotics to which they are frequently exposed.
2. Increasing resistance to antibiotics has been demonstrated and inappropriate antibiotic use continues to worsen this pattern (5).

Thus, antibiotics should be reserved for bacterial infections. References

Amsden GW. Anti-inflammatory effects of macrolides—an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother.2005 Jan;55(1):10-21. Suaudeau C, de Beaurepaire R, Rampin O, Albe-Fessard D. Antibiotics and morphinomimetic injections prevent automutilation behavior in rats after dorsal rhizotomy. Clin J Pain.1989;5(2):177–181. Ocana M, Baeyens JM. Analgesic effects of centrally administered aminoglycoside antibiotics in mice. Neurosci Lett.1991;126(1):67–70. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci.1999 Jan 1;19(1):484–494. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Zell ER, Fosheim GE, McDougal LK, Carey RB, Fridkin SK. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA.2007;298(15):1763–1771.

: Why do antibiotics work if it is not a sinus infection?

Which antibiotics reduce inflammation?

Abstract – Doxycycline is a synthetic tetracycline that was approved in 1967. This wide-spectrum antibiotic has been shown to also have useful anti-inflammatory properties that make it suitable for the treatment of a number of noninfectious conditions.

1. Tetracyclines are probably the most commonly prescribed antibiotics in dermatology, where they are usually used at doses lower than those effective against infections.
2. They also have an excellent efficacy and safety profile.
3. Because of doxycycline’s ability to inhibit the molecular pathways associated with certain processes, this antibiotic can be used to treat hair follicle diseases, granulomatous diseases, and vascular proliferation, among other conditions.

The main properties of doxycycline and its many applications in dermatology make this drug one that specialists should become familiar with.

Are antibiotics good for inflammation?

How long do I need to take antibiotics for pain and swelling? – The length of treatment will depend on the type of infection and the severity of symptoms. In general, antibiotics should be taken for the entire prescribed duration, even if symptoms improve before the medication is finished.

How quickly do antibiotics reduce inflammation?

Antibiotics are medications used to fight infections caused by bacteria. They’re also called antibacterials. They treat infections by killing or decreasing the growth of bacteria. The first modern-day antibiotic was used in 1936. Before antibiotics, 30 percent of all deaths in the United States were caused by bacterial infections.

Thanks to antibiotics, previously fatal infections are curable. Today, antibiotics are still powerful, lifesaving medications for people with certain serious infections. They can also prevent less serious infections from becoming serious. There are many classes of antibiotics. Certain types of antibiotics work best for specific types of bacterial infections.

Antibiotics come in many forms, including:

tabletscapsulesliquidscreamsointments

Most antibiotics are only available with a prescription from your doctor. Some antibiotic creams and ointments are available over the counter. Antibiotics treat bacterial infections either by killing bacteria or slowing and suspending its growth. They do this by:

attacking the wall or coating surrounding bacteriainterfering with bacteria reproductionblocking protein production in bacteria

Antibiotics begin to work right after you start taking them. However, you might not feel better for 2 to 3 days. How quickly you get better after antibiotic treatment varies. It also depends on the type of infection you’re treating. Most antibiotics should be taken for 7 to 14 days,

In some cases, shorter treatments work just as well. Your doctor will decide the best length of treatment and correct antibiotic type for you. Even though you might feel better after a few days of treatment, it’s best to finish the entire antibiotic regimen in order to fully resolve your infection. This can also help prevent antibiotic resistance.

Don’t stop your antibiotic regimen early unless your healthcare professional says you can do so. The first beta-lactam antibiotic, penicillin, was discovered by accident. It was growing from a blob of mold on a petri dish. Scientists found that a certain type of fungus naturally produced penicillin.

1. Eventually, penicillin was produced in large amounts in a laboratory through fermentation using the fungus.
2. Some other early antibiotics were produced by bacteria found in ground soil.
3. Today, all antibiotic medications are produced in a lab.
4. Some are made through a series of chemical reactions that produce the substance used in the medication.

Other antibiotics are at least partly made through a natural but controlled process. This process is often enhanced with certain chemical reactions that can alter the original substance to create a different medication. Antibiotics are powerful medications that work very well for certain types of illnesses.

• However, some antibiotics are now less useful than they once were due to an increase in antibiotic resistance.
• Antibiotic resistance occurs when bacteria can no longer be controlled or killed by certain antibiotics.
• In some cases, this can mean there are no effective treatments for certain conditions.

Each year, there are more than 2.8 million cases of bacterial infections that are resistant to antibiotics, resulting in at least 35,000 deaths. When you take an antibiotic, the sensitive bacteria are eliminated. The bacteria that survive during antibiotic treatment are often resistant to that antibiotic.

Is amoxicillin good for inflammation?

Introduction – Acute otitis media (AOM) is one of the most common infections diagnosed in early childhood. By 4 years of age, about 80% of all children will have experienced at least one episode of AOM.1 The three species of bacteria isolated most frequently in middle ear infections are Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis, 2, 3 three organisms with different potentials for causing severe disease.

Antimicrobial treatment of AOM is standard practice in most countries, independent of causative agent, and middle ear infections are currently the most common reason for outpatient antimicrobial therapy in the USA.4 The basis for this practice is the attribution of the rapid decline in incidence of mastoiditis and other intracranial complications of AOM seen in the late 1940s to the use of antibiotics.5 About 80–85% of all AOM episodes are cured with antimicrobial therapy.6 This should be compared with spontaneous clearance rates of 20% for pneumococci, 50% for H.

influenzae, and 80% for M. catarrhalis within 2–7 days.6 With increasing problems of antibiotic resistance worldwide, questions have arisen about the consequences and the efficacy of the routine use of antimicrobial agents for a relatively benign infection.7, 8 Furthermore, six out of seven children with AOM do not need or will not respond to antibiotic treatment, 9 and effusion might persist in the middle ear for weeks after an AOM, irrespective of antimicrobial therapy.6, 10 Despite the extensive use of antimicrobial agents, the data on the effects of these agents on host–parasite interactions in the middle ear cavity are limited.

• To optimize the treatment of AOM, basic knowledge of the events that take place in the middle ear during treated and untreated AOM is necessary.
• It was demonstrated recently in a rat otitis model that the majority of cytokine mRNAs had passed their peaks before the diagnosis of AOM could be made clinically, 11 indicating that the antibiotic treatment may be introduced too late to have a major impact on the inflammation or the presence of effusion.

However, amoxicillin treatment started at the clinical peak of the infection in the same model has been shown to reduce the inflammation and the histological changes induced by bacteria.12 To investigate the effects of amoxicillin in the middle ear cavity, the expression of mRNA for cytokines involved in inflammatory responses was measured during the natural course and during amoxicillin treatment of non-typeable H.

Can inflammation go away without antibiotics?

Chronic inflammation – Chronic inflammation can develop if a person has: Sensitivity : Inflammation happens when the body senses something that should not be there. Hypersensitivity to an external trigger can result in an allergy. Exposure : Sometimes, long-term, low-level exposure to an irritant, such as an industrial chemical, can result in chronic inflammation.

Autoimmune disorders: The immune system mistakenly attacks normal healthy tissue, as in psoriasis. Autoinflammatory diseases : A genetic factor affects the way the immune system works, as in Behçet’s disease. Persistent acute inflammation : In some cases, a person may not fully recover from acute inflammation.

Sometimes, this can lead to chronic inflammation. Factors that may increase the risk of chronic inflammation include :

older age obesity a diet that is rich in unhealthful fats and added sugar smoking low sex hormones stress sleep problems

Long-term diseases that doctors associate with inflammation include:

asthma chronic peptic ulcer tuberculosis rheumatoid arthritis periodontitis ulcerative colitis and Crohn’s disease sinusitis active hepatitis

Inflammation plays a vital role in healing, but chronic inflammation may increase the risk of various diseases, including some cancers, rheumatoid arthritis, atherosclerosis, periodontitis, and hay fever, The following table summarizes some key differences between acute and chronic inflammation.

It is essential to identify and manage inflammation and related diseases to prevent further complications. Acute inflammation can cause pain of varying types and severity. Pain may be constant and steady, throbbing and pulsating, stabbing, or pinching. Pain results when the buildup of fluid leads to swelling, and the swollen tissues push against sensitive nerve endings.

Other biochemical processes also occur during inflammation. They affect how nerves behave, and this can contribute to pain. Treatment of inflammation will depend on the cause and severity. Often, there is no need for treatment. Sometimes, however, not treating inflammation can result in life threatening symptoms.

Does reducing inflammation speed up healing?

Reducing Inflammation to Help Relieve Pain and Injury Musculoskeletal injuries that lead to swelling are common for athletes and non-athletes alike. Every day Physical Therapists treat patients suffering from pain and limited use of the injured area caused by inflammation.

Does ibuprofen help with inflammation?

Descriptions – Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain, and helps to relieve symptoms of arthritis (osteoarthritis, rheumatoid arthritis, or juvenile arthritis), such as inflammation, swelling, stiffness, and joint pain.

1. This medicine does not cure arthritis and will help you only as long as you continue to take it,
2. In addition, ibuprofen can be used to treat fever, menstrual cramps, and other conditions as determined by your doctor,
3. This medicine is available both over-the-counter (OTC) and with your doctor’s prescription,

This product is available in the following dosage forms:

• Tablet, Chewable
• Tablet
• Suspension
• Capsule, Liquid Filled

What is the strongest anti-inflammatory drug?

Frequently Asked Questions –

Is ibuprofen or naproxen better for inflammation? There isn’t much head-to-head research comparing the two. One older study found that both were effective for relieving the symptoms of knee arthritis, but naproxen helped with more symptoms, such as night pain. In general, ibuprofen takes effect and wears off more quickly, while naproxen has a slower onset but lasts longer. Can I take ibuprofen and naproxen together? No. Ibuprofen and naproxen are both NSAIDs. Taking more than one NSAID at a time is not recommended because it can increase the risk of adverse effects like stomach issues and bleeding. What is the strongest anti-inflammatory medication? Research shows diclofenac is the strongest and most effective non-steroidal anti-inflammatory medicine available. Diclofenec is sold under the prescription brand names Cambia, Cataflam, Zipsor, and Zorvolex. It is also available as a topical gel, Voltaren, which is available over the counter. What are the signs of inflammation? Inflammation is the body’s immune response to an injury or illness. Acute inflammation causes redness, swelling, heat, pain, and loss of function in the area that is inflamed. How can I reduce inflammation quickly? Follow the RICE formula for managing inflammation due to an acute injury—rest, ice, compression, and elevation. For systemic inflammation, following an anti-inflammatory diet can help in the long term. NSAIDs and corticosteroids are often recommended for fast relief of pain and inflammation.

How long is too long for inflammation?

Introduction – Inflammation is part of the body’s defense mechanism. It is the process by which the immune system recognizes and removes harmful and foreign stimuli and begins the healing process. Inflammation can be either acute or chronic. Acute Inflammation Tissue damage due to trauma, microbial invasion, or noxious compounds can induce acute inflammation.

• It starts rapidly, becomes severe in a short time and symptoms may last for a few days for example cellulitis or acute pneumonia.
• Subacute inflammation is the period between acute and chronic inflammation and may last 2 to 6 weeks.
• Chronic Inflammation Chronic inflammation is also referred to as slow, long-term inflammation lasting for prolonged periods of several months to years.

Generally, the extent and effects of chronic inflammation vary with the cause of the injury and the ability of the body to repair and overcome the damage. This article reviews chronic inflammation.

Why won’t my inflammation go away?

You may be able to manage chronic inflammation with medication and diet changes. Some foods, including leafy greens, nuts, and fruit, may help reduce inflammation in the body. Inflammation refers to your body’s process of fighting against things that harm it, like infections, injuries, and toxins, in an attempt to heal itself.

1. When something damages your cells, your body releases chemicals that trigger a response from your immune system,
2. This response includes the release of antibodies and proteins, as well as increased blood flow to the damaged area.
3. In the case of acute inflammation — like getting a cut on your knee or dealing with a cold — the whole process usually lasts for a few hours or a few days.

Chronic inflammation happens when this response lingers, leaving your body in a constant state of alert. Over time, chronic inflammation may have a negative impact on your tissues and organs. Some research suggests that chronic inflammation could also play a role in a range of conditions, from cancer to stroke,

fatigue body pain depression or anxiety gastrointestinal complications ( diarrhea or constipation )weight gainweight losspersistent infections

These symptoms can range from mild to severe and last for several months or years. Several things can cause chronic inflammation, including:

untreated causes of acute inflammation, like an infection or injuryan autoimmune disorder, which involves your immune system mistakenly attacking healthy tissuelong-term exposure to irritants, like industrial chemicals or polluted air

Keep in mind that these issues don’t cause chronic inflammation in everyone. In addition, some cases of chronic inflammation don’t have a clear underlying cause. Experts also believe that a range of factors may also contribute to chronic inflammation, like:

smoking obesity alcohol chronic stress

When you’re living with chronic inflammation, your body’s inflammatory response can eventually start damaging healthy cells, tissues, and organs. Over time, this can lead to DNA damage, tissue death, and internal scarring, All of these are linked to the development of several diseases, including:

cancer heart disease rheumatoid arthritis type 2 diabetes obesity asthma cognitive decline and dementia (in older adults)

There are no real tests to diagnose inflammation on its own. But certain blood tests are a good starting point, including ones that highlight C-reactive protein (CRP), which indicates infections or inflammation in the general body (like the joints), and high-sensitivity C-reactive protein (hsCRP), which reflects inflammation of the heart.

Many individuals don’t know they have chronic inflammation until they’re diagnosed with another condition. If you feel like you’re experiencing some of the common symptoms of chronic inflammation, it’s a good idea to speak with your doctor. They’ll know the first steps to take when it comes to a diagnosis.

Inflammation is a natural part of the healing process. But when it becomes chronic, it’s important to try to get it under control to reduce your risk of long-term damage. Some of the options that’ve been explored for managing inflammation include:

Nonsteroidal anti-inflammatory drugs (NSAIDs). Over-the-counter NSAIDs, like aspirin, ibuprofen (Advil), and naproxen (Aleve), effectively reduce inflammation and pain. But long-term use is linked to an increased risk of several conditions, including peptic ulcer disease and kidney disease. Steroids. Corticosteroids are a type of steroid hormone. They decrease inflammation and suppress the immune system, which is helpful when it starts attacking healthy tissue. But long-term use of corticosteroids can lead to vision problems, high blood pressure, and osteoporosis, When prescribing corticosteroids, your doctor will weigh the benefits and risks with you. Supplements. Certain supplements may help to reduce inflammation. Fish oil, lipoic acid, and curcumin have all been linked to decreased inflammation — although more studies need to be done, especially around fish oil, to say for sure. Several spices may also help with chronic inflammation and inflammatory disease, including ginger, garlic, and cayenne, but again, more research around optimal dosage and definitive statements need to be done. Lifestyle changes, Losing weight (if your doctor recommends it), increasing physical activity, and dietary changes (like a low glycemic diet and reduced saturated fat intake), have all been shown to help lower inflammation.

What you eat can play both a positive and negative role in managing chronic inflammation.

Why is inflammation not healing?

References – 1. Nguyen A.V., Soulika A.M. The Dynamics of the Skin’s Immune System. Int.J. Mol. Sci.2019; 20 :1811. doi: 10.3390/ijms20081811.2. Zhao R., Liang H., Clarke E., Jackson C., Xue M. Inflammation in Chronic Wounds. Int.J. Mol. Sci.2016; 17 :2085. doi: 10.3390/ijms17122085.3.

Järbrink K., Ni G., Sönnergren H., Schmidtchen A., Pang C., Bajpai R., Car J. Prevalence and incidence of chronic wounds and related complications: A protocol for a systematic review. Syst. Rev.2016; 5 :152. doi: 10.1186/s13643-016-0329-y.4. Olsson M., Järbrink K., Divakar U., Bajpai R., Upton Z., Schmidtchen A., Car J.

The humanistic and economic burden of chronic wounds: A systematic review. Wound Repair Regen.2019; 27 :114–125. doi: 10.1111/wrr.12683.5. Raziyeva K., Kim Y., Zharkinbekov Z., Kassymbek K., Jimi S., Saparov A. Immunology of Acute and Chronic Wound Healing.

Biomolecules.2021; 11 :700. doi: 10.3390/biom11050700.6. Mustoe T.A., O’Shaughnessy K., Kloeters O. Chronic wound pathogenesis and current treatment strategies: A unifying hypothesis. Plast. Reconstr. Surg.2006; 117 :35s–41s. doi: 10.1097/01.prs.0000225431.63010.1b.7. Harding K. Innovation and wound healing.J.

Wound Care.2015; 24 :7–13. doi: 10.12968/jowc.2015.24.Sup4b.7.8. Ashtikar M., Wacker M.G. Nanopharmaceuticals for wound healing-Lost in translation? Adv. Drug Deliv Rev.2018; 129 :194–218. doi: 10.1016/j.addr.2018.03.005.9. Sharma A., Khanna S., Kaur G., Singh I.

Medicinal plants and their components for wound healing applications. Future J. Pharm. Sci.2021; 7 :53. doi: 10.1186/s43094-021-00202-w.10. Kirsner R.S., Eaglstein W.H. The wound healing process. Derm. Clin.1993; 11 :629–640. doi: 10.1016/S0733-8635(18)30216-X.11. Van der Veer W.M., Bloemen M.C., Ulrich M.M., Molema G., van Zuijlen P.P., Middelkoop E., Niessen F.B.

Potential cellular and molecular causes of hypertrophic scar formation. Burns.2009; 35 :15–29. doi: 10.1016/j.burns.2008.06.020.12. Rosique R.G., Rosique M.J., Farina Junior J.A. Curbing Inflammation in Skin Wound Healing: A Review. Int.J. Inflam.2015; 2015 :316235.

1. Doi: 10.1155/2015/316235.13.
2. Schultz G.S., Davidson J.M., Kirsner R.S., Bornstein P., Herman I.M.
3. Dynamic reciprocity in the wound microenvironment.
4. Wound Repair Regen.2011; 19 :134–148.
5. Doi: 10.1111/j.1524-475X.2011.00673.x.15.
6. Cañedo-Dorantes L., Cañedo-Ayala M.
7. Skin Acute Wound Healing: A Comprehensive Review.

Int.J. Inflamm.2019; 2019 :3706315. doi: 10.1155/2019/3706315.16. Eming S.A., Martin P., Tomic-Canic M. Wound repair and regeneration: Mechanisms, signaling, and translation. Sci. Transl. Med.2014; 6 :sr6–sr265. doi: 10.1126/scitranslmed.3009337.17. Cowin A., Adams D., Strudwick X., Chan H., Hooper J., Sander G., Rayner T., Matthaei K., Powell B., Campbell H.

• Flightless I deficiency enhances wound repair by increasing cell migration and proliferation.J.
• Pathol.2007; 211 :572–581.
• Doi: 10.1002/path.2143.18.
• Julier Z., Park A.J., Briquez P.S., Martino M.M.
• Promoting tissue regeneration by modulating the immune system.
• Acta Biomater.2017; 53 :13–28.
• Doi: 10.1016/j.actbio.2017.01.056.19.

Mast B.A., Schultz G.S. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen.1996; 4 :411–420. doi: 10.1046/j.1524-475X.1996.40404.x.20. Xu Z., Liang B., Tian J., Wu J. Anti-inflammation biomaterial platforms for chronic wound healing.

Biomater. Sci.2021; 9 :4388–4409. doi: 10.1039/D1BM00637A.21. Champeau M., Póvoa V., Militão L., Cabrini F.M., Picheth G.F., Meneau F., Jara C.P., de Araujo E.P., de Oliveira M.G. Supramolecular poly(acrylic acid)/F127 hydrogel with hydration-controlled nitric oxide release for enhancing wound healing. Acta Biomater.2018; 74 :312–325.

doi: 10.1016/j.actbio.2018.05.025.22. Dunnill C., Patton T., Brennan J., Barrett J., Dryden M., Cooke J., Leaper D., Georgopoulos N.T. Reactive oxygen species (ROS) and wound healing: The functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process.

1. Int. Wound J.2017; 14 :89–96.
2. Doi: 10.1111/iwj.12557.23.
3. Hong W.X., Hu M.S., Esquivel M., Liang G.Y., Rennert R.C., McArdle A., Paik K.J., Duscher D., Gurtner G.C., Lorenz H.P., et al.
4. The Role of Hypoxia-Inducible Factor in Wound Healing. Adv.
5. Wound Care.2014; 3 :390–399.
6. Doi: 10.1089/wound.2013.0520.24.
7. Malone-Povolny M.J., Maloney S.E., Schoenfisch M.H.

Nitric Oxide Therapy for Diabetic Wound Healing. Adv. Healthc. Mater.2019; 8 :e1801210. doi: 10.1002/adhm.201801210.25. Wu Y.K., Cheng N.C., Cheng C.M. Biofilms in Chronic Wounds: Pathogenesis and Diagnosis. Trends Biotechnol.2019; 37 :505–517. doi: 10.1016/j.tibtech.2018.10.011.26.

• Omar A., Wright J.B., Schultz G., Burrell R., Nadworny P.
• Microbial Biofilms and Chronic Wounds.
• Microorganisms.2017; 5 :9.
• Doi: 10.3390/microorganisms5010009.27.
• MacLeod A.S., Mansbridge J.N.
• The Innate Immune System in Acute and Chronic Wounds. Adv.
• Wound Care.2016; 5 :65–78.
• Doi: 10.1089/wound.2014.0608.28.

Strbo N., Yin N., Stojadinovic O. Innate and Adaptive Immune Responses in Wound Epithelialization. Adv. Wound Care.2014; 3 :492–501. doi: 10.1089/wound.2012.0435.29. Wilgus T.A., Roy S., McDaniel J.C. Neutrophils and Wound Repair: Positive Actions and Negative Reactions.

• Adv. Wound Care.2013; 2 :379–388.
• Doi: 10.1089/wound.2012.0383.30.
• Zhu S., Yu Y., Ren Y., Xu L., Wang H., Ling X., Jin L., Hu Y., Zhang H., Miao C., et al.
• The emerging roles of neutrophil extracellular traps in wound healing.
• Cell Death Dis.2021; 12 :984.
• Doi: 10.1038/s41419-021-04294-3.31.
• Ellis S., Lin E.J., Tartar D.

Immunology of Wound Healing. Curr. Dermatol. Rep.2018; 7 :350–358. doi: 10.1007/s13671-018-0234-9.32. Widgerow A.D. Cellular resolution of inflammation-catabasis. Wound Repair Regen.2012; 20 :2–7. doi: 10.1111/j.1524-475X.2011.00754.x.33. Nguyen T.T., Ding D., Wolter W.R., Pérez R.L., Champion M.M., Mahasenan K.V., Hesek D., Lee M., Schroeder V.A., Jones J.I., et al.

1. Validation of Matrix Metalloproteinase-9 (MMP-9) as a Novel Target for Treatment of Diabetic Foot Ulcers in Humans and Discovery of a Potent and Selective Small-Molecule MMP-9 Inhibitor That Accelerates Healing.J. Med.
2. Chem.2018; 61 :8825–8837.
3. Doi: 10.1021/acs.jmedchem.8b01005.34.
4. Lang J., Yang C., Liu L., Li L., Wu L., Liu Y., Luo H., Yan L., Chen S., Ning J., et al.

High glucose activates ERK1/2 to stabilize AP1 and increase MMP9 expression in diabetic foot ulcers. Exp. Cell Res.2021; 403 :112550. doi: 10.1016/j.yexcr.2021.112550.35. Demidova-Rice T.N., Hamblin M.R., Herman I.M. Acute and impaired wound healing: Pathophysiology and current methods for drug delivery, part 1: Normal and chronic wounds: Biology, causes, and approaches to care.

1. Adv. Skin Wound Care.2012; 25 :304–314.
2. Doi: 10.1097/01.ASW.0000416006.55218.d0.36.
3. Han G., Havnaer A., Lee H.H., Carmichael D.J., Martinez L.R.
4. Biological depletion of neutrophils attenuates pro-inflammatory markers and the development of the psoriatic phenotype in a murine model of psoriasis. Clin.
5. Immunol.2020; 210 :108294.

doi: 10.1016/j.clim.2019.108294.37. Yang S., Gu Z., Lu C., Zhang T., Guo X., Xue G., Zhang L. Neutrophil Extracellular Traps Are Markers of Wound Healing Impairment in Patients with Diabetic Foot Ulcers Treated in a Multidisciplinary Setting. Adv. Wound Care.2020; 9 :16–27.

doi: 10.1089/wound.2019.0943.38. Kohno K., Koya-Miyata S., Harashima A., Tsukuda T., Katakami M., Ariyasu T., Ushio S., Iwaki K. Inflammatory M1-like macrophages polarized by NK-4 undergo enhanced phenotypic switching to an anti-inflammatory M2-like phenotype upon co-culture with apoptotic cells.J. Inflamm.2021; 18 :2.

doi: 10.1186/s12950-020-00267-z.39. Kimball A.S., Davis F.M., denDekker A., Joshi A.D., Schaller M.A., Bermick J., Xing X., Burant C.F., Obi A.T., Nysz D., et al. The Histone Methyltransferase Setdb2 Modulates Macrophage Phenotype and Uric Acid Production in Diabetic Wound Repair.

1. Immunity.2019; 51 :258–271.e5.
2. Doi: 10.1016/j.immuni.2019.06.015.40.
3. Liechty C., Hu J., Zhang L., Liechty K.W., Xu J.
4. Role of microRNA-21 and Its Underlying Mechanisms in Inflammatory Responses in Diabetic Wounds. Int.J. Mol.
5. Sci.2020; 21 :3328.
6. Doi: 10.3390/ijms21093328.41.
7. DiPietro L.A., Wilgus T.A., Koh T.J.

Macrophages in Healing Wounds: Paradoxes and Paradigms. Int.J. Mol. Sci.2021; 22 :950. doi: 10.3390/ijms22020950.42. Feng Y., Sun Z.L., Liu S.Y., Wu J.J., Zhao B.H., Lv G.Z., Du Y., Yu S., Yang M.L., Yuan F.L., et al. Direct and Indirect Roles of Macrophages in Hypertrophic Scar Formation.

1. Front. Physiol.2019; 10 :1101.
2. Doi: 10.3389/fphys.2019.01101.43.
3. Vivier E., van de Pavert S.A., Cooper M.D., Belz G.T.
4. The evolution of innate lymphoid cells. Nat.
5. Immunol.2016; 17 :790–794.
6. Doi: 10.1038/ni.3459.44.
7. Hams E., Bermingham R., Fallon P.G.
8. Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis.

Front. Immunol.2015; 6 :597. doi: 10.3389/fimmu.2015.00597.45. Rak G.D., Osborne L.C., Siracusa M.C., Kim B.S., Wang K., Bayat A., Artis D., Volk S.W. IL-33-Dependent Group 2 Innate Lymphoid Cells Promote Cutaneous Wound Healing.J. Investig. Dermatol.2016; 136 :487–496.

doi: 10.1038/JID.2015.406.46. Yin H., Li X., Hu S., Liu T., Yuan B., Gu H., Ni Q., Zhang X., Zheng F. IL-33 accelerates cutaneous wound healing involved in upregulation of alternatively activated macrophages. Mol. Immunol.2013; 56 :347–353. doi: 10.1016/j.molimm.2013.05.225.47. Molofsky A.B., Van Gool F., Liang H.-E., Van Dyken S.J., Nussbaum J.C., Lee J., Bluestone J.A., Locksley R.M.

Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation. Immunity.2015; 43 :161–174. doi: 10.1016/j.immuni.2015.05.019.48. Imai Y., Yasuda K., Sakaguchi Y., Haneda T., Mizutani H., Yoshimoto T., Nakanishi K., Yamanishi K.

Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc. Natl. Acad. Sci. USA.2013; 110 :13921–13926. doi: 10.1073/pnas.1307321110.49. Larouche J., Sheoran S., Maruyama K., Martino M.M. Immune Regulation of Skin Wound Healing: Mechanisms and Novel Therapeutic Targets.

Adv. Wound Care.2018; 7 :209–231. doi: 10.1089/wound.2017.0761.50. Strang H., Kaul A., Parikh U., Masri L., Saravanan S., Li H., Miao Q., Balaji S. Chapter 11-Role of cytokines and chemokines in wound healing. In: Bagchi D., Das A., Roy S., editors. Wound Healing, Tissue Repair, and Regeneration in Diabetes.

Academic Press; Cambridge, MA, USA: 2020. pp.197–235.51. Berchiche Y.A., Sakmar T.P. CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways. Mol. Pharmacol.2016; 90 :483–495. doi: 10.1124/mol.116.105502.52. Kuo P.T., Zeng Z., Salim N., Mattarollo S., Wells J.W., Leggatt G.R.

The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer. Front. Med.2018; 5 :271. doi: 10.3389/fmed.2018.00271.53. Eming S.A., Hammerschmidt M., Krieg T., Roers A. Interrelation of immunity and tissue repair or regeneration. Semin. Cell Dev. Biol.2009; 20 :517–527.

doi: 10.1016/j.semcdb.2009.04.009.54. Seraphim P.M., Leal E.C., Moura J., Gonçalves P., Gonçalves J.P., Carvalho E. Lack of lymphocytes impairs macrophage polarization and angiogenesis in diabetic wound healing. Life Sci.2020; 254 :117813. doi: 10.1016/j.lfs.2020.117813.55. Kalekar L.A., Rosenblum M.D. Regulatory T cells in inflammatory skin disease: From mice to humans.

Int. Immunol.2019; 31 :457–463. doi: 10.1093/intimm/dxz020.56. Sîrbulescu R.F., Boehm C.K., Soon E., Wilks M.Q., Ilies I., Yuan H., Maxner B., Chronos N., Kaittanis C., Normandin M., et al. Mature B cells accelerate wound healing after acute and chronic diabetic skin lesions.

• Wound Repair Regen.2017; 25 :774–791.
• Doi: 10.1111/wrr.12584.57.
• Versey Z., da Cruz Nizer W.S., Russell E., Zigic S., DeZeeuw K.G., Marek J.E., Overhage J., Cassol E.
• Biofilm-Innate Immune Interface: Contribution to Chronic Wound Formation. Front.
• Immunol.2021; 12 :648554.
• Doi: 10.3389/fimmu.2021.648554.58.

Cardona A.F., Wilson S.E. Skin and Soft-Tissue Infections: A Critical Review and the Role of Telavancin in Their Treatment. Clin. Infect. Dis.2015; 61 ((Suppl.2)):S69–S78. doi: 10.1093/cid/civ528.59. Caley M.P., Martins V.L.C., O’Toole E.A. Metalloproteinases and Wound Healing.

• Adv. Wound Care.2015; 4 :225–234.
• Doi: 10.1089/wound.2014.0581.60.
• Wolcott R.D., Hanson J.D., Rees E.J., Koenig L.D., Phillips C.D., Wolcott R.A., Cox S.B., White J.S.
• Analysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing.
• Wound Repair Regen.2016; 24 :163–174.
• Doi: 10.1111/wrr.12370.61.

Rudresh S.M., Ravi G.S., Alex A.M., Mamatha K.R., Sunitha L., Ramya K.T. Non Diphtheritic Corynebacteria: An Emerging Nosocomial Pathogen in Skin and Soft Tissue Infection.J. Clin. Diagn Res.2015; 9 :DC19–DC21. doi: 10.7860/JCDR/2015/15580.6977.62. Yin W., Wang Y., Liu L., He J.

1. Biofilms: The Microbial “Protective Clothing” in Extreme Environments. Int.J. Mol.
2. Sci.2019; 20 :3423.
3. Doi: 10.3390/ijms20143423.63.
4. Awadh A.A., Le Gresley A., Forster-Wilkins G., Kelly A.F., Fielder M.D.
5. Determination of metabolic activity in planktonic and biofilm cells of Mycoplasma fermentans and Mycoplasma pneumoniae by nuclear magnetic resonance.

Sci. Rep.2021; 11 :5650. doi: 10.1038/s41598-021-84326-2.65. Burmølle M., Thomsen T.R., Fazli M., Dige I., Christensen L., Homøe P., Tvede M., Nyvad B., Tolker-Nielsen T., Givskov M., et al. Biofilms in chronic infections-a matter of opportunity-monospecies biofilms in multispecies infections.

FEMS Immunol. Med. Microbiol.2010; 59 :324–336. doi: 10.1111/j.1574-695X.2010.00714.x.66. Bjarnsholt T. The role of bacterial biofilms in chronic infections. APMIS Suppl.2013; 121 :1–51. doi: 10.1111/apm.12099.67. Bakshani C.R., Morales-Garcia A.L., Althaus M., Wilcox M.D., Pearson J.P., Bythell J.C., Burgess J.G.

Evolutionary conservation of the antimicrobial function of mucus: A first defence against infection. NPJ Biofilms Microbiomes.2018; 4 :14. doi: 10.1038/s41522-018-0057-2.68. Tomic-Canic M., Burgess J.L., O’Neill K.E., Strbo N., Pastar I. Skin Microbiota and its Interplay with Wound Healing.

• Am.J. Clin.
• Derm.2020; 21 ((Suppl.1)):36–43.
• Doi: 10.1007/s40257-020-00536-w.69.
• Richmond N.A., Maderal A.D., Vivas A.C.
• Evidence-based management of common chronic lower extremity ulcers. Dermatol.
• Ther.2013; 26 :187–196.
• Doi: 10.1111/dth.12051.70.
• Frykberg R.G., Banks J.
• Challenges in the Treatment of Chronic Wounds.

Adv. Wound Care.2015; 4 :560–582. doi: 10.1089/wound.2015.0635.71. Phalak P., Henson M.A. Metabolic modelling of chronic wound microbiota predicts mutualistic interactions that drive community composition.J. Appl. Microbiol.2019; 127 :1576–1593. doi: 10.1111/jam.14421.72.

Percival S.L., Thomas J.G., Williams D.W. Biofilms and bacterial imbalances in chronic wounds: Anti-Koch. Int. Wound J.2010; 7 :169–175. doi: 10.1111/j.1742-481X.2010.00668.x.73. Wilson M. Bacterial biofilms and human disease. Pt 3 Sci. Prog.2001; 84 :235–254. doi: 10.3184/003685001783238998.74. Donlan R.M., Costerton J.W.

Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev.2002; 15 :167–193. doi: 10.1128/CMR.15.2.167-193.2002.75. Wolcott R.D., Rhoads D.D., Dowd S.E. Biofilms and chronic wound inflammation.J. Wound Care.2008; 17 :333–341.

doi: 10.12968/jowc.2008.17.8.30796.76. Cano Sanchez M., Lancel S., Boulanger E., Neviere R. Targeting Oxidative Stress and Mitochondrial Dysfunction in the Treatment of Impaired Wound Healing: A Systematic Review. Antioxidants.2018; 7 :98. doi: 10.3390/antiox7080098.77. He L., He T., Farrar S., Ji L., Liu T., Ma X.

Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species. Cell Physiol. Biochem.2017; 44 :532–553. doi: 10.1159/000485089.78. Comino-Sanz I.M., López-Franco M.D., Castro B., Pancorbo-Hidalgo P.L. The Role of Antioxidants on Wound Healing: A Review of the Current Evidence.J.

• Clin. Med.2021; 10 :3558.
• Doi: 10.3390/jcm10163558.79.
• Artem Ataide J., Caramori Cefali L., Machado Croisfelt F., Arruda Martins Shimojo A., Oliveira-Nascimento L., Gava Mazzola P.
• Natural actives for wound healing: A review.
• Phytother.
• Res.2018; 32 :1664–1674.
• Doi: 10.1002/ptr.6102.80.
• Thangapazham R.L., Sharad S., Maheshwari R.K.

Phytochemicals in Wound Healing. Adv. Wound Care.2016; 5 :230–241. doi: 10.1089/wound.2013.0505.81. Shukla S.K., Sharma A.K., Gupta V., Yashavarddhan M.H. Pharmacological control of inflammation in wound healing.J. Tissue Viability.2019; 28 :218–222. doi: 10.1016/j.jtv.2019.09.002.82.

• Hussain T., Tan B., Yin Y., Blachier F., Tossou M.C., Rahu N.
• Oxidative Stress and Inflammation: What Polyphenols Can Do for Us? Oxid. Med. Cell.
• Longev.2016; 2016 :7432797.
• Doi: 10.1155/2016/7432797.83.
• Yadav D.K., Kumar S., Choi E.-H., Chaudhary S., Kim M.-H.
• Molecular dynamic simulations of oxidized skin lipid bilayer and permeability of reactive oxygen species.

Sci. Rep.2019; 9 :4496. doi: 10.1038/s41598-019-40913-y.84. Simões D., Miguel S.P., Ribeiro M.P., Coutinho P., Mendonça A.G., Correia I.J. Recent advances on antimicrobial wound dressing: A review. Eur.J. Pharm. Biopharm.2018; 127 :130–141. doi: 10.1016/j.ejpb.2018.02.022.85.

Polat Yemiş G., Delaquis P. Natural Compounds With Antibacterial Activity Against Cronobacter spp. in Powdered Infant Formula: A Review. Front. Nutr.2020; 7 :595964. doi: 10.3389/fnut.2020.595964.86. Działo M., Mierziak J., Korzun U., Preisner M., Szopa J., Kulma A. The Potential of Plant Phenolics in Prevention and Therapy of Skin Disorders.

Int.J. Mol. Sci.2016; 17 :160. doi: 10.3390/ijms17020160.87. Ghuman S., Ncube B., Finnie J.F., McGaw L.J., Mfotie Njoya E., Coopoosamy R.M., Van Staden J. Antioxidant, anti-inflammatory and wound healing properties of medicinal plant extracts used to treat wounds and dermatological disorders.S.

• Afr.J. Bot.2019; 126 :232–240.
• Doi: 10.1016/j.sajb.2019.07.013.88.
• Guimarães I., Baptista-Silva S., Pintado M., Oliveira A.L.
• Polyphenols: A Promising Avenue in Therapeutic Solutions for Wound Care. Appl.
• Sci.2021; 11 :1230.
• Doi: 10.3390/app11031230.89.
• Wu T., He M., Zang X., Zhou Y., Qiu T., Pan S., Xu X.
• A structure–activity relationship study of flavonoids as inhibitors of E.

coli by membrane interaction effect. Biochim. Biophys. Acta Biomembr.2013; 1828 :2751–2756. doi: 10.1016/j.bbamem.2013.07.029.90. Su Y., Ma L., Wen Y., Wang H., Zhang S. Studies of the in vitro antibacterial activities of several polyphenols against clinical isolates of methicillin-resistant Staphylococcus aureus.

1. Molecules.2014; 19 :12630–12639.
2. Doi: 10.3390/molecules190812630.91.
3. Umar S., Pandey A.K.
4. Chemistry and biological activities of flavonoids: An overview. Sci.
5. World J.2013; 2013 :162750.
6. Doi: 10.1155/2013/162750.92.
7. Carvalho M.T.B., Araújo-Filho H.G., Barreto A.S., Quintans-Júnior L.J., Quintans J.S.S., Barreto R.S.S.

Wound healing properties of flavonoids: A systematic review highlighting the mechanisms of action. Phytomedicine.2021; 90 :153636. doi: 10.1016/j.phymed.2021.153636.93. Singh W.R., Devi H.S., Kumawat S., Sadam A., Appukuttan A.V., Patel M.R., Lingaraju M.C., Singh T.U., Kumar D.

Angiogenic and MMPs modulatory effects of icariin improved cutaneous wound healing in rats. Eur.J. Pharm.2019; 858 :172466. doi: 10.1016/j.ejphar.2019.172466.94. Hu W.-H., Wang H.-Y., Xia Y.-T., Dai D.K., Xiong Q.-P., Dong T.T.-X., Duan R., Chan G.K.-L., Qin Q.-W., Tsim K.W.-K. Kaempferol, a Major Flavonoid in Ginkgo Folium, Potentiates Angiogenic Functions in Cultured Endothelial Cells by Binding to Vascular Endothelial Growth Factor.

Front. Pharmacol.2020; 11 :526. doi: 10.3389/fphar.2020.00526.95. Ranneh Y., Akim A.M., Hamid H.A., Khazaai H., Fadel A., Zakaria Z.A., Albujja M., Bakar M.F.A. Honey and its nutritional and anti-inflammatory value. BMC Complement. Med. Ther.2021; 21 :30. doi: 10.1186/s12906-020-03170-5.96.

1. Robson V., Dodd S., Thomas S.
2. Standardized antibacterial honey (Medihoney) with standard therapy in wound care: Randomized clinical trial.J. Adv.
3. Nurs.2009; 65 :565–575.
4. Doi: 10.1111/j.1365-2648.2008.04923.x.97.
5. Othman L., Sleiman A., Abdel-Massih R.M.
6. Antimicrobial Activity of Polyphenols and Alkaloids in Middle Eastern Plants.

Front. Microbiol.2019; 10 :911. doi: 10.3389/fmicb.2019.00911.98. Grzesik M., Bartosz G., Dziedzic A., Narog D., Namiesnik J., Sadowska-Bartosz I. Antioxidant properties of ferrous flavanol mixtures. Food Chem.2018; 268 :567–576. doi: 10.1016/j.foodchem.2018.06.076.99.

Nagle D.G., Ferreira D., Zhou Y.-D. Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives. Phytochemistry.2006; 67 :1849–1855. doi: 10.1016/j.phytochem.2006.06.020.100. Lin Y.H., Tsai M.J., Fang Y.P., Fu Y.S., Huang Y.B., Wu P.C. Microemulsion formulation design and evaluation for hydrophobic compound: Catechin topical application.

Colloids Surf. B Biointerfaces.2018; 161 :121–128. doi: 10.1016/j.colsurfb.2017.10.015.101. Grzesik M., Naparło K., Bartosz G., Sadowska-Bartosz I. Antioxidant properties of catechins: Comparison with other antioxidants. Food Chem.2018; 241 :480–492. doi: 10.1016/j.foodchem.2017.08.117.102.

• Im E., Hwang K., Lee J., Han S.Y., Kim E.M., Park J., Cho J.Y.
• Skin Protective Effect of Epigallocatechin Gallate. Int.J. Mol.
• Sci.2018; 19 :173.
• Doi: 10.3390/ijms19010173.103.
• Roy M., Chakrabarty S., Sinha D., Bhattacharya R.K., Siddiqi M.
• Anticlastogenic, antigenotoxic and apoptotic activity of epigallocatechin gallate: A green tea polyphenol.

Mutat. Res. Fundam. Mol. Mech. Mutagenesis.2003; 523–524 :33–41. doi: 10.1016/S0027-5107(02)00319-6.104. Kuroda Y., Hara Y. Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat. Res.1999; 436 :69–97. doi: 10.1016/S1383-5742(98)00019-2.105. Huang Y.W., Zhu Q.Q., Yang X.Y., Xu H.H., Sun B., Wang X.J., Sheng J.

Wound healing can be improved by (-)-epigallocatechin gallate through targeting Notch in streptozotocin-induced diabetic mice. FASEB J.2019; 33 :953–964. doi: 10.1096/fj.201800337R.106. Li Y., Yao J., Han C., Yang J., Chaudhry M.T., Wang S., Liu H., Yin Y. Quercetin, Inflammation and Immunity. Nutrients.2016; 8 :167.

doi: 10.3390/nu8030167.107. Aceituno-Medina M., Mendoza S., Rodríguez B.A., Lagaron J.M., López-Rubio A. Improved antioxidant capacity of quercetin and ferulic acid during in-vitro digestion through encapsulation within food-grade electrospun fibers.J.

Funct. Foods.2015; 12 :332–341. doi: 10.1016/j.jff.2014.11.028.108. Tran H.A., Ly K.L., Fox K.E., Tran P.A., Nguyen T.H. Immobilization of Antimicrobial Silver and Antioxidant Flavonoid as a Coating for Wound Dressing Materials. Int.J. Nanomed.2019; 14 :9929–9939. doi: 10.2147/IJN.S230214.109. Gomathi K., Gopinath D., Rafiuddin Ahmed M., Jayakumar R.

Quercetin incorporated collagen matrices for dermal wound healing processes in rat. Biomaterials.2003; 24 :2767–2772. doi: 10.1016/S0142-9612(03)00059-0.110. Yin G., Wang Z., Wang Z., Wang X. Topical application of quercetin improves wound healing in pressure ulcer lesions.

• Exp. Derm.2018; 27 :779–786.
• Doi: 10.1111/exd.13679.111.
• Fu J., Huang J., Lin M., Xie T., You T.
• Quercetin Promotes Diabetic Wound Healing via Switching Macrophages from M1 to M2 Polarization.J. Surg.
• Res.2019; 246 :213–223.
• Doi: 10.1016/j.jss.2019.09.011.112.
• Sogo T., Terahara N., Hisanaga A., Kumamoto T., Yamashiro T., Wu S., Sakao K., Hou D.X.

Anti-inflammatory activity and molecular mechanism of delphinidin 3-sambubioside, a Hibiscus anthocyanin. Biofactors.2015; 41 :58–65. doi: 10.1002/biof.1201.113. Nanashima N., Horie K., Maeda H., Tomisawa T., Kitajima M., Nakamura T. Blackcurrant Anthocyanins Increase the Levels of Collagen, Elastin, and Hyaluronic Acid in Human Skin Fibroblasts and Ovariectomized Rats.

• Nutrients.2018; 10 :495.
• Doi: 10.3390/nu10040495.114.
• Marton L.T., Pescinini E.S.L.M., Camargo M.E.C., Barbalho S.M., Haber J., Sinatora R.V., Detregiachi C.R.P., Girio R.J.S., Buchaim D.V., Cincotto Dos Santos Bueno P.
• The Effects of Curcumin on Diabetes Mellitus: A Systematic Review. Front.
• Endocrinol.2021; 12 :669448.

doi: 10.3389/fendo.2021.669448.115. Priyadarsini K.I. The Chemistry of Curcumin: From Extraction to Therapeutic Agent. Molecules.2014; 19 :20091–20112. doi: 10.3390/molecules191220091.116. Rujirachotiwat A., Suttamanatwong S. Curcumin upregulates transforming growth factor-β1, its receptors, and vascular endothelial growth factor expressions in an in vitro human gingival fibroblast wound healing model.

1. BMC Oral Health.2021; 21 :535.
2. Doi: 10.1186/s12903-021-01890-9.117.
3. Shah A., Amini-Nik S.
4. The Role of Phytochemicals in the Inflammatory Phase of Wound Healing. Int.J. Mol.
5. Sci.2017; 18 :1068.
6. Doi: 10.3390/ijms18051068.118.
7. Makuch S., Więcek K., Woźniak M.
8. The Immunomodulatory and Anti-Inflammatory Effect of Curcumin on Immune Cell Populations, Cytokines, and In Vivo Models of Rheumatoid Arthritis.

Pharmaceuticals.2021; 14 :309. doi: 10.3390/ph14040309.119. Liu J., Chen Z., Wang J., Li R., Li T., Chang M., Yan F., Wang Y. Encapsulation of Curcumin Nanoparticles with MMP9-Responsive and Thermos-Sensitive Hydrogel Improves Diabetic Wound Healing. ACS Appl.

Mater. Interfaces.2018; 10 :16315–16326. doi: 10.1021/acsami.8b03868.120. Yang D.J., Moh S.H., Son D.H., You S., Kinyua A.W., Ko C.M., Song M., Yeo J., Choi Y.H., Kim K.W. Gallic Acid Promotes Wound Healing in Normal and Hyperglucidic Conditions. Molecules.2016; 21 :899. doi: 10.3390/molecules21070899.121.

Coppo E., Marchese A. Antibacterial activity of polyphenols. Curr. Pharm. Biotechnol.2014; 15 :380–390. doi: 10.2174/138920101504140825121142.122. Jackson J.K., Zhao J., Wong W., Burt H.M. The inhibition of collagenase induced degradation of collagen by the galloyl-containing polyphenols tannic acid, epigallocatechin gallate and epicatechin gallate.J.

1. Mater. Sci. Mater.
2. Med.2010; 21 :1435–1443.
3. Doi: 10.1007/s10856-010-4019-3.123.
4. Li K., Diao Y., Zhang H., Wang S., Zhang Z., Yu B., Huang S., Yang H.
5. Tannin extracts from immature fruits of Terminalia chebula Fructus Retz.
6. Promote cutaneous wound healing in rats.
7. BMC Complement. Altern.
8. Med.2011; 11 :86.
9. Doi: 10.1186/1472-6882-11-86.124.

Cowan M.M. Plant products as antimicrobial agents. Clin. Microbiol. Rev.1999; 12 :564–582. doi: 10.1128/CMR.12.4.564.125. Brownlee H., McEuen A.B., Hedger J.N., Scott I.M. Anti-fungal effects of cocoa tannin on the witches’ broom pathogen Crinipellis perniciosa.

1. Physiol. Mol. Plant.
2. Pathol.1990; 36 :39–48.
3. Doi: 10.1016/0885-5765(90)90090-K.126.
4. Jones G.A., McAllister T.A., Muir A.D., Cheng K.J.
5. Effects of Sainfoin ( Onobrychis viciifolia Scop.) Condensed Tannins on Growth and Proteolysis by Four Strains of Ruminal Bacteria. Appl. Environ.
6. Microbiol.1994; 60 :1374–1378.

doi: 10.1128/aem.60.4.1374-1378.1994.127. Chokotho L., van Hasselt E. The use of tannins in the local treatment of burn wounds-a pilot study. Malawi Med.J.2005; 17 :19–20. doi: 10.4314/mmj.v17i1.10866.128. Shohayeb L.M., Abdel-Hameed E.-S.S., Bazaid S.A. Antimicrobial activity of tannins and extracts of different parts of conocarpus erectus.

1. Int.J. Pharm. Bio.
2. Sci.2013; 3 :544–553.129.
3. Al-Daihan S., Al-Faham M., Al-shawi N., Almayman R., Brnawi A., Zargar S., Bhat R.S.
4. Antibacterial activity and phytochemical screening of some medicinal plants commonly used in Saudi Arabia against selected pathogenic microorganisms.J.
5. Ing Saud Univ.
6. Sci.2013; 25 :115–120.

doi: 10.1016/j.jksus.2012.11.003.130. Yassin M.T., Mostafa A.A., Al Askar A.A. In Vitro Evaluation of Biological Activities and Phytochemical Analysis of Different Solvent Extracts of Punica granatum L. (Pomegranate) Peels. Plants.2021; 10 :2742. doi: 10.3390/plants10122742.131.

1. Marques F.Z., Markus M.A., Morris B.J.
2. Resveratrol: Cellular actions of a potent natural chemical that confers a diversity of health benefits. Int.J. Biochem.
3. Cell Biol.2009; 41 :2125–2128.
4. Doi: 10.1016/j.biocel.2009.06.003.132.
5. Onyalioglu S., Armagan G., Yalcin A., Atalayin C., Dagci T.
6. Effects of resveratrol on hydrogen peroxide-induced oxidative stress in embryonic neural stem cells.

Neural Regen. Res.2013; 8 :485–495.134. Saqib U., Faisal S.M., Saluja R., Baig M.S. Structural insights of resveratrol with its binding partners in the toll-like receptor 4 pathway.J. Cell Biochem.2019; 120 :452–460. doi: 10.1002/jcb.27401.135. Lai C.Y., Su Y.W., Lin K.I., Hsu L.C., Chuang T.H.

• Natural Modulators of Endosomal Toll-like Receptor-Mediated Psoriatic Skin Inflammation.J. Immunol.
• Res.2017; 2017 :7807313.
• Doi: 10.1155/2017/7807313.136.
• Youn H.S., Lee J.Y., Fitzgerald K.A., Young H.A., Akira S., Hwang D.H.
• Specific Inhibition of MyD88-Independent Signaling Pathways of TLR3 and TLR4 by Resveratrol: Molecular Targets Are TBK1 and RIP1 in TRIF Complex.J.

Immunol.2005; 175 :3339–3346. doi: 10.4049/jimmunol.175.5.3339.137. Bashmakov Y.K., Assaad-Khalil S.H., Abou Seif M., Udumyan R., Megallaa M., Rohoma K.H., Zeitoun M., Petyaev I.M. Resveratrol promotes foot ulcer size reduction in type 2 diabetes patients.

ISRN Endocrinol.2014; 2014 :816307. doi: 10.1155/2014/816307.138. Khanna S., Venojarvi M., Roy S., Sharma N., Trikha P., Bagchi D., Bagchi M., Sen C.K. Dermal wound healing properties of redox-active grape seed proanthocyanidins. Free Radic. Biol. Med.2002; 33 :1089–1096. doi: 10.1016/S0891-5849(02)00999-1.139.

Lakshmanan R., Campbell J., Ukani G., O’Reilly Beringhs A., Selvaraju V., Thirunavukkarasu M., Lu X., Palesty J.A., Maulik N. Evaluation of dermal tissue regeneration using resveratrol loaded fibrous matrix in a preclinical mouse model of full-thickness ischemic wound.

• Int.J. Pharm.2019; 558 :177–186.
• Doi: 10.1016/j.ijpharm.2019.01.001.140. Chan M.M.
• Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin. Biochem.
• Pharm.2002; 63 :99–104.
• Doi: 10.1016/S0006-2952(01)00886-3.141.
• Shevelev A.B., La Porta N., Isakova E.P., Martens S., Biryukova Y.K., Belous A.S., Sivokhin D.A., Trubnikova E.V., Zylkova M.V., Belyakova A.V., et al.

In Vivo Antimicrobial and Wound-Healing Activity of Resveratrol, Dihydroquercetin, and Dihydromyricetin against Staphylococcus aureus, Pseudomonas aeruginosa, and Candida albicans. Pathogens.2020; 9 :296. doi: 10.3390/pathogens9040296.142. Draganescu D., Ibanescu C., Tamba B.I., Andritoiu C.V., Dodi G., Popa M.I.

Flaxseed lignan wound healing formulation: Characterization and in vivo therapeutic evaluation. Int.J. Biol. Macromol.2015; 72 :614–623. doi: 10.1016/j.ijbiomac.2014.09.012.143. De Cássia da Silveira e Sá R., Andrade L.N., de Sousa D.P. A review on anti-inflammatory activity of monoterpenes. Molecules.2013; 18 :1227–1254.

doi: 10.3390/molecules18011227.144. Miguel M.G. Antioxidant and anti-inflammatory activities of essential oils: A short review. Molecules.2010; 15 :9252–9287. doi: 10.3390/molecules15129252.145. Orchard A., van Vuuren S. Commercial Essential Oils as Potential Antimicrobials to Treat Skin Diseases.

• Evid. Based Complementary Alternat.
• Med.2017; 2017 :4517971.
• Doi: 10.1155/2017/4517971.146.
• Salas-Oropeza J., Jimenez-Estrada M., Perez-Torres A., Castell-Rodriguez A.E., Becerril-Millan R., Rodriguez-Monroy M.A., Jarquin-Yañez K., Canales-Martinez M.M.
• Wound Healing Activity of α-Pinene and α-Phellandrene.

Molecules.2021; 26 :2488. doi: 10.3390/molecules26092488.147. Unlü M., Daferera D., Dönmez E., Polissiou M., Tepe B., Sökmen A. Compositions and the in vitro antimicrobial activities of the essential oils of Achillea setacea and Achillea teretifolia (Compositae) J.

• Ethnopharmacol.2002; 83 :117–121.
• Doi: 10.1016/S0378-8741(02)00218-0.148.
• Almeida J.R.G.d.S., Souza G.R., Silva J.C., Saraiva S.R.G.d.L., Júnior R.G.d.O., Quintans J.d.S.S., Barreto R.d.S.S., Bonjardim L.R., Cavalcanti S.C.d.H., Junior L.J.Q.
• Borneol, a Bicyclic Monoterpene Alcohol, Reduces Nociceptive Behavior and Inflammatory Response in Mice.

Sci. World J.2013; 2013 :808460. doi: 10.1155/2013/808460.149. Kordali S., Kotan R., Mavi A., Cakir A., Ala A., Yildirim A. Determination of the chemical composition and antioxidant activity of the essential oil of Artemisia dracunculus and of the antifungal and antibacterial activities of Turkish Artemisia absinthium, A.

1. Dracunculus, Artemisia santonicum, and Artemisia spicigera essential oils.J. Agric.
2. Food Chem.2005; 53 :9452–9458.150.
3. Dai J.P., Chen J., Bei Y.F., Han B.X., Wang S.
4. Influence of borneol on primary mice oral fibroblasts: A penetration enhancer may be used in oral submucous fibrosis.J.
5. Oral Pathol.
6. Med.2009; 38 :276–281.

doi: 10.1111/j.1600-0714.2008.00738.x.151. Knobloch K., Pauli A., Iberl B., Weigand H., Weis N. Antibacterial and Antifungal Properties of Essential Oil Components.J. Essent. Oil Res.1989; 1 :119–128. doi: 10.1080/10412905.1989.9697767.152. Tabanca N., Kirimer N., Demirci B., Demirci F., Başer K.H.

• Composition and antimicrobial activity of the essential oils of Micromeria cristata subsp.
• Phrygia and the enantiomeric distribution of borneol.J. Agric.
• Food Chem.2001; 49 :4300–4303.
• Doi: 10.1021/jf0105034.153.
• Liu R., Zhang L., Lan X., Li L., Zhang T.T., Sun J.H., Du G.H.
• Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion: Involvement of anti-oxidation and anti-inflammation through nuclear transcription factor κappaB signaling pathway.

Neuroscience.2011; 176 :408–419. doi: 10.1016/j.neuroscience.2010.11.029.154. Memar M.Y., Raei P., Alizadeh N., Akbari Aghdam M., Kafil H.S. Carvacrol and thymol: Strong antimicrobial agents against resistant isolates. Rev. Med. Microbiol.2017; 28 :63–68. doi: 10.1097/MRM.0000000000000100.155.

• Marino M., Bersani C., Comi G.
• Antimicrobial activity of the essential oils of Thymus vulgaris L.
• Measured using a bioimpedometric method.J.
• Food Prot.1999; 62 9 :1017–1023.
• Doi: 10.4315/0362-028X-62.9.1017.156.
• Marchese A., Orhan I.E., Daglia M., Barbieri R., Di Lorenzo A., Nabavi S.F., Gortzi O., Izadi M., Nabavi S.M.

Antibacterial and antifungal activities of thymol: A brief review of the literature. Food Chem.2016; 210 :402–414. doi: 10.1016/j.foodchem.2016.04.111.157. Braga P.C., Dal Sasso M., Culici M., Bianchi T., Bordoni L., Marabini L. Anti-Inflammatory Activity of Thymol: Inhibitory Effect on the Release of Human Neutrophil Elastase.

• Pharmacology.2006; 77 :130–136.
• Doi: 10.1159/000093790.158.
• Youdim K.A., Deans S.G.
• Effect of thyme oil and thymol dietary supplementation on the antioxidant status and fatty acid composition of the ageing rat brain. Br.J.
• Nutr.2000; 83 :87–93.
• Doi: 10.1017/S000711450000012X.159.
• Yanishlieva N.V., Marinova E.M., Gordon M.H., Raneva V.G.

Antioxidant activity and mechanism of action of thymol and carvacrol in two lipid systems. Food Chem.1999; 64 :59–66. doi: 10.1016/S0308-8146(98)00086-7.160. Vulgare I., Montana S., Processes T. In vitro activity of the essential oils of Origanum vulgare, Satureja montana and their main constituents in peroxynitrite-induced oxidative processes.

Food Chem.2007; 104 :889–895.161. Riella K.R., Marinho R.R., Santos J.S., Pereira-Filho R.N., Cardoso J.C., Albuquerque-Junior R.L., Thomazzi S.M. Anti-inflammatory and cicatrizing activities of thymol, a monoterpene of the essential oil from Lippia gracilis, in rodents.J. Ethnopharmacol.2012; 143 :656–663.

doi: 10.1016/j.jep.2012.07.028.162. Mollarafie P., Parsi P., Zarghami R., Fazl M., Ghafarzadegan R. Antibacterial and Wound Healing Properties of Thymol (Thymus Vulgaris Oil) and its Application in a Novel Wound Dressing.J. Med. Plants.2015; 14 :69–81.163.

Costa M., Durço A., Rabelo T.K., Siqueira R., Guimarães A. Effects of Carvacrol, Thymol and essential oils containing such monoterpenes on wound healing: A systematic review.J. Pharm. Pharmacol.2018; 71 :141–155. doi: 10.1111/jphp.13054.164. Khaleel C., Tabanca N., Buchbauer G. α-Terpineol, a natural monoterpene: A review of its biological properties.

Open Chem.2018; 16 :349–361. doi: 10.1515/chem-2018-0040.165. Kawata J.K., Kameda M., Miyazawa M. Cyclooxygenase-2 inhibitory effects of monoterpenoids with a p-methane skeleton. Int.J. Essent. Oil Ther.2008; 2 :145–148.166. De Oliveira M.G., Marques R.B., de Santana M.F., Santos A.B., Brito F.A., Barreto E.O., De Sousa D.P., Almeida F.R., Badauê-Passos D., Jr., Antoniolli A.R., et al.

• Α-terpineol reduces mechanical hypernociception and inflammatory response.
• Basic Clin. Pharm.
• Toxicol.2012; 111 :120–125.
• Doi: 10.1111/j.1742-7843.2012.00875.x.167.
• Park S.N., Lim Y.K., Freire M.O., Cho E., Jin D., Kook J.K.
• Antimicrobial effect of linalool and α-terpineol against periodontopathic and cariogenic bacteria.

Anaerobe.2012; 18 :369–372. doi: 10.1016/j.anaerobe.2012.04.001.168. Park M.J., Gwak K.S., Yang I., Kim K.W., Jeung E.B., Chang J.W., Choi I.G. Effect of citral, eugenol, nerolidol and alpha-terpineol on the ultrastructural changes of Trichophyton mentagrophytes.

Fitoterapia.2009; 80 :290–296. doi: 10.1016/j.fitote.2009.03.007.169. Sonboli A., Esmaeili M.A., Gholipour A., Kanani M.R. Composition, cytotoxicity and antioxidant activity of the essential oil of Dracocephalum surmandinum from Iran. Nat. Prod. Commun.2010; 5 :341–344. doi: 10.1177/1934578X1000500234.170.

D’Alessio P.A., Mirshahi M., Bisson J.F., Bene M.C. Skin repair properties of d-Limonene and perillyl alcohol in murine models. Antiinflamm Antiallergy Agents Med. Chem.2014; 13 :29–35. doi: 10.2174/18715230113126660021.171. De Lima V.T., Vieira M.C., Kassuya C.A., Cardoso C.A., Alves J.M., Foglio M.A., de Carvalho J.E., Formagio A.S.

1. Chemical composition and free radical-scavenging, anticancer and anti-inflammatory activities of the essential oil from Ocimum kilimandscharicum.
2. Phytomedicine.2014; 21 :1298–1302.
3. Doi: 10.1016/j.phymed.2014.07.004.172.
4. Bogacz-Radomska L., Harasym J.
5. Β-Carotene—properties and production methods.
6. Food Qual.

Saf.2018; 2 :69–74. doi: 10.1093/fqsafe/fyy004.173. Balić A., Mokos M. Do We Utilize Our Knowledge of the Skin Protective Effects of Carotenoids Enough? Antioxidants.2019; 8 :259. doi: 10.3390/antiox8080259.174. Kaulmann A., Bohn T. Carotenoids, inflammation, and oxidative stress-implications of cellular signaling pathways and relation to chronic disease prevention.

Nutr. Res.2014; 34 :907–929. doi: 10.1016/j.nutres.2014.07.010.175. Lenucci M.S., Cadinu D., Taurino M., Piro G., Dalessandro G. Antioxidant composition in cherry and high-pigment tomato cultivars.J. Agric. Food Chem.2006; 54 :2606–2613. doi: 10.1021/jf052920c.176. Feng D., Ling W.H., Duan R.D. Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-kappaB in macrophages.

Inflamm. Res.2010; 59 :115–121. doi: 10.1007/s00011-009-0077-8.177. Palozza P., Colangelo M., Simone R., Catalano A., Boninsegna A., Lanza P., Monego G., Ranelletti F.O. Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines.

1. Carcinogenesis.2010; 31 :1813–1821.
2. Doi: 10.1093/carcin/bgq157.178.
3. Arppi J., Nurmi T., Kurl S., Rissanen T.H., Nyyssönen K.
4. Lycopene, lutein and beta-carotene as determinants of LDL conjugated dienes in serum.
5. Atherosclerosis.2010; 209 :565–572.
6. Doi: 10.1016/j.atherosclerosis.2009.10.007.179.
7. Brotosudarmo T.H.P., Limantara L., Setiyono E.

Heriyanto, Structures of Astaxanthin and Their Consequences for Therapeutic Application. Int.J. Food Sci.2020; 2020 :2156582. doi: 10.1155/2020/2156582.180. Tominaga K., Hongo N., Fujishita M., Takahashi Y., Adachi Y. Protective effects of astaxanthin on skin deterioration.J.

1. Clin. Biochem.
2. Nutr.2017; 61 :33–39.
3. Doi: 10.3164/jcbn.17-35.181.
4. Ritto D., Tanasawet S., Singkhorn S., Klaypradit W., Hutamekalin P., Tipmanee V., Sukketsiri W.
5. Astaxanthin induces migration in human skin keratinocytes via Rac1 activation and RhoA inhibition. Nutr. Res.
6. Pr.2017; 11 :275–280.
7. Doi: 10.4162/nrp.2017.11.4.275.182.

Imokawa G. Intracellular Signaling Mechanisms Involved in the Biological Effects of the Xanthophyll Carotenoid Astaxanthin to Prevent the Photo-aging of the Skin in a Reactive Oxygen Species Depletion-independent Manner: The Key Role of Mitogen and Stress-activated Protein Kinase 1.

Photochem. Photobiol.2019; 95 :480–489.183. Meephansan J., Rungjang A., Yingmema W., Deenonpoe R., Ponnikorn S. Effect of astaxanthin on cutaneous wound healing. Clin. Cosmet Investig. Derm.2017; 10 :259–265. doi: 10.2147/CCID.S142795.184. Viaña-Mendieta P., Sánchez M.L., Benavides J. Rational selection of bioactive principles for wound healing applications: Growth factors and antioxidants.

Int. Wound J.2022; 19 :100–113. doi: 10.1111/iwj.13602.185. Sommerburg O., Keunen J.E., Bird A.C., van Kuijk F.J. Fruits and vegetables that are sources for lutein and zeaxanthin: The macular pigment in human eyes. Br.J. Ophthalmol.1998; 82 :907–910. doi: 10.1136/bjo.82.8.907.186.

Eisenhauer B., Natoli S., Liew G., Flood V.M. Lutein and Zeaxanthin—Food Sources, Bioavailability and Dietary Variety in Age-Related Macular Degeneration Protection. Nutrients.2017; 9 :120. doi: 10.3390/nu9020120.187. Wingerath T., Sies H., Stahl W. Xanthophyll esters in human skin. Arch. Biochem. Biophys.1998; 355 :271–274.

doi: 10.1006/abbi.1998.0734.188. Roberts R.L., Green J., Lewis B. Lutein and zeaxanthin in eye and skin health. Clin. Derm.2009; 27 :195–201. doi: 10.1016/j.clindermatol.2008.01.011.189. McNulty H.P., Byun J., Lockwood S.F., Jacob R.F., Mason R.P. Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysis.

1. Biochim. Biophy.
2. Acta.2007; 1768 :167–174.
3. Doi: 10.1016/j.bbamem.2006.09.010.190.
4. Li R., Turner S.D., Brautigan D.L.
5. Xanthophylls lutein and zeaxanthin modify gene expression and induce synthesis of hyaluronan in keratinocyte model of human skin. Biochem. Biophy.
6. Rep.2015; 4 :52–58.
7. Doi: 10.1016/j.bbrep.2015.08.012.191.

Neag M.A., Mocan A., Echeverría J., Pop R.M., Bocsan C.I., Crişan G., Buzoianu A.D. Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders. Front. Pharmacol.2018; 9 :557.

doi: 10.3389/fphar.2018.00557.192. Boberek J.M., Stach J., Good L. Genetic Evidence for Inhibition of Bacterial Division Protein FtsZ by Berberine. PLoS ONE.2010; 5 :e13745. doi: 10.1371/journal.pone.0013745.193. Sun N., Chan F.Y., Lu Y.J., Neves M.A., Lui H.K., Wang Y., Chow K.Y., Chan K.F., Yan S.C., Leung Y.C., et al.

Rational design of berberine-based FtsZ inhibitors with broad-spectrum antibacterial activity. PLoS ONE.2014; 9 :e97514. doi: 10.1371/journal.pone.0097514.194. Imenshahidi M., Hosseinzadeh H. Berberine and barberry ( Berberis vulgaris ): A clinical review.

Phytother Res.2019; 33 :504–523. doi: 10.1002/ptr.6252.195. Zhou R., Xiang C., Cao G., Xu H., Zhang Y., Yang H., Zhang J. Berberine accelerated wound healing by restoring TrxR1/JNK in diabetes. Clin. Sci.2021; 135 :613–627. doi: 10.1042/CS20201145.196. Zhang P., He L., Zhang J., Mei X., Zhang Y., Tian H., Chen Z.

Preparation of novel berberine nano-colloids for improving wound healing of diabetic rats by acting Sirt1/NF-κB pathway. Colloids Surf. B Biointerfaces.2020; 187 :110647. doi: 10.1016/j.colsurfb.2019.110647.197. Kim E.-K., Jeong E.-K., Han S.-B., Hong J.

HPLC Separation of Isoquinoline Alkaloids for Quality Control of Corydalis species. Bull. Korean Chem. Soc.2011; 32 :3597–3602. doi: 10.5012/bkcs.2011.32.10.3597.198. Ma B.L., Ma Y.M. Pharmacokinetic properties, potential herb-drug interactions and acute toxicity of oral Rhizoma coptidis alkaloids. Expert Opin.

Drug Metab. Toxicol.2013; 9 :51–61. doi: 10.1517/17425255.2012.722995.199. Chen X., Wang R., Bao C., Zhang J., Zhang J., Li R., Wu S., Wen J., Yang T., Wei S., et al. Palmatine ameliorates Helicobacter pylori-induced chronic atrophic gastritis by inhibiting MMP-10 through ADAM17/EGFR.

• Eur.J. Pharm.2020; 882 :173267.
• Doi: 10.1016/j.ejphar.2020.173267.200.
• Üpeli E., Koşar M., Yeşilada E., Hüsnü K., Başer C.
• A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species.
• Life Sci.2002; 72 :645–657.

doi: 10.1016/S0024-3205(02)02200-2.201. Yan B., Wang D., Dong S., Cheng Z., Na L., Sang M., Yang H., Yang Z., Zhang S., Yan Z. Palmatine inhibits TRIF-dependent NF-κB pathway against inflammation induced by LPS in goat endometrial epithelial cells. Int.

• Immunopharmacol.2017; 45 :194–200.
• Doi: 10.1016/j.intimp.2017.02.004.202.
• Jiang Z., Zhao L., He F., Tan H., Li Y., Tang Y., Duan X., Li Y.
• Palmatine-loaded electrospun poly(ε-caprolactone)/gelatin nanofibrous scaffolds accelerate wound healing and inhibit hypertrophic scar formation in a rabbit ear model.J.

Biomater. Appl.2021; 35 :869–886. doi: 10.1177/0885328220950060.203. Lee Y.H., Chang J.J., Chien C.T., Yang M.C., Chien H.F. Antioxidant sol-gel improves cutaneous wound healing in streptozotocin-induced diabetic rats. Exp. Diabetes Res.2012; 2012 :504693.

• Doi: 10.1155/2012/504693.204.
• Huang J., Chen L., Gu Z., Wu J.
• Red Jujube-Incorporated Gelatin Methacryloyl (GelMA) Hydrogels with Anti-Oxidation and Immunoregulation Activity for Wound Healing.J. Biomed.
• Nanotechnol.2019; 15 :1357–1370.
• Doi: 10.1166/jbn.2019.2815.205.
• Aggarwal B.B., Sundaram C., Prasad S., Kannappan R.

Tocotrienols, the vitamin E of the 21st century: Its potential against cancer and other chronic diseases. Biochem. Pharm.2010; 80 :1613–1631. doi: 10.1016/j.bcp.2010.07.043.206. Freedman J.E., Keaney J.F., Jr. Vitamin E inhibition of platelet aggregation is independent of antioxidant activity.J.

1. Nutr.2001; 131 :374s–377s.
2. Doi: 10.1093/jn/131.2.374S.207.
3. Lobo V., Patil A., Phatak A., Chandra N.
4. Free radicals, antioxidants and functional foods: Impact on human health. Pharm.
5. Rev.2010; 4 :118–126.
6. Doi: 10.4103/0973-7847.70902.208.
7. Shukla A., Rasik A.M., Patnaik G.K.
8. Depletion of reduced glutathione, ascorbic acid, vitamin E and antioxidant defence enzymes in a healing cutaneous wound.

Free Radic. Res.1997; 26 :93–101. doi: 10.3109/10715769709097788.209. Musalmah M., Nizrana M.Y., Fairuz A.H., NoorAini A.H., Azian A.L., Gapor M.T., Wan Ngah W.Z. Comparative effects of palm vitamin E and alpha-tocopherol on healing and wound tissue antioxidant enzyme levels in diabetic rats.

• Lipids.2005; 40 :575–580.
• Doi: 10.1007/s11745-005-1418-9.210.
• Lin T.S., Abd Latiff A., Abd Hamid N.A., Wan Ngah W.Z.B., Mazlan M.
• Evaluation of Topical Tocopherol Cream on Cutaneous Wound Healing in Streptozotocin-Induced Diabetic Rats. Evid.
• Based Complementary Altern.
• Med.2012; 2012 :491027.
• Doi: 10.1155/2012/491027.211.

Shin J., Yang S.J., Lim Y. Gamma-tocopherol supplementation ameliorated hyper-inflammatory response during the early cutaneous wound healing in alloxan-induced diabetic mice. Exp. Biol. Med.2017; 242 :505–515. doi: 10.1177/1535370216683836.212. Xu C., Bentinger M., Savu O., Moshfegh A., Sunkari V., Dallner G., Swiezewska E., Catrina S.B., Brismar K., Tekle M.

Mono-epoxy-tocotrienol-α enhances wound healing in diabetic mice and stimulates in vitro angiogenesis and cell migration.J. Diabetes Complicat.2017; 31 :4–12. doi: 10.1016/j.jdiacomp.2016.10.010.213. Hu H., Tang Y., Pang L., Lin C., Huang W., Wang D., Jia W. Angiogenesis and Full-Thickness Wound Healing Efficiency of a Copper-Doped Borate Bioactive Glass/Poly(lactic-co-glycolic acid) Dressing Loaded with Vitamin E in Vivo and in Vitro.

ACS Appl. Mater. Interfaces.2018; 10 :22939–22950. doi: 10.1021/acsami.8b04903.214. Galeano M., Torre V., Deodato B., Campo G.M., Colonna M., Sturiale A., Squadrito F., Cavallari V., Cucinotta D., Buemi M., et al. Raxofelast, a hydrophilic vitamin E-like antioxidant, stimulates wound healing in genetically diabetic mice.

Surgery.2001; 129 :467–477.215. Barbosa E., Faintuch J., Machado Moreira E.A., Gonçalves da Silva V.R., Lopes Pereima M.J., Martins Fagundes R.L., Filho D.W. Supplementation of vitamin E, vitamin C, and zinc attenuates oxidative stress in burned children: A randomized, double-blind, placebo-controlled pilot study.J.

Burn. Care Res.2009; 30 :859–866. doi: 10.1097/BCR.0b013e3181b487a8.216. Zampieri N., Zuin V., Burro R., Ottolenghi A., Camoglio F.S. A prospective study in children: Pre- and post-surgery use of vitamin E in surgical incisions.J. Plast Reconstr Aesthet Surg.2010; 63 :1474–1478.

Doi: 10.1016/j.bjps.2009.08.018.217. Pierpaoli E., Orlando F., Cirioni O., Simonetti O., Giacometti A., Provinciali M. Supplementation with tocotrienols from Bixa orellana improves the in vivo efficacy of daptomycin against methicillin-resistant Staphylococcus aureus in a mouse model of infected wound.

Phytomedicine.2017; 36 :50–53. doi: 10.1016/j.phymed.2017.09.011.218. Provinciali M., Cirioni O., Orlando F., Pierpaoli E., Barucca A., Silvestri C., Ghiselli R., Scalise A., Brescini L., Guerrieri M., et al. Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus.J.

How long does it take to reverse inflammation in the body?

Topical analgesics and other creams – Topical analgesics are typically used for acute or chronic pain. They may have less side effects than an oral counterpart. Topical creams and products can contain different medications. Some are prescription only, so it’s best to get advice from your doctor.

This is especially the case if you’re treating long-term inflammation, like with arthritis, Some topicals contain an NSAID like diclofenac or ibuprofen. This can be helpful for people with inflammation and pain in a specific body part. Other topical creams may contain natural ingredients that have some evidence of anti-inflammatory properties.

Make sure you don’t use a topical cream that only works for pain, such as capsaicin, Inflammation is a normal and natural part of your body’s immune response. Yet, long-term or chronic inflammation can lead to damaging effects. It seems to be associated more often with autoimmune disorders.

• Acute inflammation is a normal part of the healing process and may occur when you’re experiencing a sore throat or even a small cut on your skin.
• Acute inflammation should go away within a few days, unless it’s left untreated.
• If you’re experiencing any signs of long-term inflammation, make an appointment with your doctor.

They can run some tests and review your symptoms to see if you need treatment for any underlying conditions.

How long does it take for amoxicillin to reduce inflammation?

Amoxicillin fights infections in the body within an hour after taking it. The penicillin-based medication gets its strength from consistent use of multiple doses per day. Amoxicillin often relieves symptoms in less than 72 hours and stays in your system for 24 hours.